Skip to content

Clinical trials

Phase 1 Graft vs Host Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 1 Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20033
20043
20073
20088
20101
20111
20122
20133
20143
20156
20162
20172
20184
20192
20207
20215
20221
20231
20243
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated15
Recruiting9
Withdrawn4
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
Dana-Farber Cancer Institute4
Baylor College of Medicine3
H. Lee Moffitt Cancer Center and Research Institute3
MedImmune LLC3
National Institute of Allergy and Infectious Diseases (NIAID)3
Northwestern University3
Washington University School of Medicine3
City of Hope Medical Center2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease78
Myelodysplastic Syndromes20
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Leukemia13
Leukemia, Lymphocytic, Chronic, B-Cell13
Leukemia, Myeloid, Acute13
Lymphoma13
Multiple Myeloma12
Lymphoma, Non-Hodgkin11
Hodgkin Disease10

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.